Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
PDS Biotechnology Corporation (PDSB) had Normalized Income after Taxes of $-7.35M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-7.35M |
|
-- |
|
-- |
|
$6.52M |
|
$-6.52M |
|
$-0.83M |
|
$-7.35M |
|
$-7.35M |
|
$-7.35M |
|
$-7.35M |
|
$-7.35M |
|
|
Normalized Income after Taxes |
$-7.35M |
$-6.52M |
|
$-6.06M |
|
55.50M |
|
55.50M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$22.89M |
|
$0.11M |
|
$1.78M |
|
$24.66M |
|
$10.15M |
|
$10.62M |
|
$10.62M |
|
$20.77M |
|
$3.89M |
|
$3.89M |
|
$3.89M |
|
55.82M |
|
| Cash Flow Statement Financials | |
$-4.37M |
|
-- |
|
$-0.68M |
|
$26.71M |
|
$21.66M |
|
$-5.05M |
|
$1.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.26 |
|
-- |
|
-- |
|
0.73 |
|
4.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-188.79% |
|
-188.79% |
|
-29.80% |
|
-50.63% |
|
$0.07 |
|
$-0.08 |
|
$-0.08 |
|